Acute right ventricular failure (RVF) is prevalent in multiple disease states and is associated with poor clinical outcomes. Right-sided temporary mechanical circulatory support (tMCS) devices are used to unload RV congestion and increase cardiac output in cardiogenic shock (CS) with hemodynamically significant RVF. Several RV-tMCS device platforms are available; however consensus is lacking on patient selection, timing of escalation to RV-tMCS, device management, and device weaning. The purposes of this review are to 1) describe the current state of tMCS device therapies for acute RVF with CS, 2) discuss principles of escalation to RV-tMCS device therapy, 3) examine important aspects of clinical management for patients supported by RV-tMCS devices including volume management, anticoagulation, and positive pressure ventilation, and 4) provide a framework for RV-tMCS weaning.

The JHLT Digital Media Editors host a discussion with senior author Stefan Schwarz, MD, PhD, on lung transplant patients with suspicious lung lesions.

Hear about how temperature storage affects donor hearts on a molecular level from Gaurav Sharma of the University of Texas Southwestern Medical Center on JHLT: The Podcast.

Hiroto Shimokawahara of the Okayama Medical Center in Japan discusses outcomes for stent-based pulmonary angioplasty in peripheral pulmonary artery stenosis (PPAS).

Katelynn Madill-Thomsen and Philip Halloran of the Alberta Transplant Applied Genomics Center discuss how donor-specific antibodies show up in patients with and without AMR in heart transplantation.

Heart transplant recipient and patient advocate Payton Herres discusses the problems of 'ghost approval' and the difference between health insurance coverage and access to care.

JHLT will release a special issue in the first quarter of 2027 dedicated to manuscripts focused on precision medicine across the patient journey. Submissions for this issue are now being accepted unti...

JHLT will release a special issue in the first quarter of 2027 dedicated to manuscripts focused on precision medicine across the patient journey. Submissions for this issue are now being accepted unti...

The JHLT will release a special issue in Q4 2026 dedicated to manuscripts exploring aspects of donor selection and organ preservation related to thoracic transplantation. Submissions will be accepted ...

Learn more about mechanical circulatory support and other device therapies for diagnosis, serial monitoring, and/or treatment of patients in JHLT and on the podcast.

JHLT Digital Media Editors bring on guest Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, to discuss lung cancer after lung transplantation, and the management of these complex patients.

The first of two themed conversations around HIV in solid organ transplant by discussions a paper on heart transplant using HIV+ donors with Omar Saeed of Montefiore Medical Center in New York.

The JHLT team discusses a study from Aarhus University Hospital in Denmark on the impact evolocumab may have on coronary physiology and microstructure in de-novo heart transplant recipients.

First author Muhtadi Alnababteh, MD, and senior author Michael Keller, MD, are on the podcast this month to discuss the impact of DSAs on longitudinal lung function and BLAD.

Nir Uriel, MD appears on JHLT: The Podcast to discuss the work of the Cardiogenic Shock Working Group and their recent paper on the outcomes of patients supported on Impella 5.5 .

Ahmet Bilgili and Eric Jeng, MD, of the University of Florida, are on JHLT the Podcast to discuss optimal pre-transplant duration for HeartMate III LVADs.